Literature DB >> 10407066

Stabilized plasmid-lipid particles: factors influencing plasmid entrapment and transfection properties.

K W Mok1, A M Lam, P R Cullis.   

Abstract

Previous work has shown that plasmid DNA can be encapsulated in small 'stabilized plasmid-lipid particles' (SPLP) composed of 1, 2-dioleyl-3-phosphatidylethanolamine (DOPE), the cationic lipid N, N-dioleyl-N,N-dimethylammonium chloride (DODAC) and poly(ethylene glycol) (PEG) conjugated ceramides (PEG-Cer), employing a detergent dialysis procedure. These SPLP have potential as vectors for in vivo gene therapy. This study is aimed at characterizing the influence of the cationic lipid and PEG-Cer species on SPLP formation and in vitro transfection properties. It is shown that the transfection potency of SPLP is sensitive to the cationic lipid species employed, the size of the PEG polymer incorporated in the PEG-ceramide and the length of the acyl chain contained in the ceramide anchor. With regard to the influence of cationic lipid, the transfection levels achieved were highest for SPLP containing N-[2, 3-(dioleyloxy)propyl]-N,N-dimethyl-N-cyanomethylammonium chloride (DODMA-AN) and lowest for SPLP containing 3-beta-[N-(N', N'-dimethylaminoethyl)carbamoyl]-cholesterol (DC-CHOL), according to the series DODMA-AN>N-[2,3-(dioleyloxy)propyl]-N,N, N-trimethylammonium chloride (DOTMA)>DODAC>N,N-distearyl-N, N-dimethylammonium chloride (DSDAC)>DC-CHOL. Incorporation of short (PEG(750)) PEG polymers in the PEG-ceramide components resulted in modest improvements in transfection levels over PEG(2000) and PEG(5000) polymers, however variation of the length of the acyl chain contained in the hydrophobic ceramide anchor from octanoyl (PEG-CerC(8)) to myristoyl (PEG-CerC(14)) to arachidoyl (PEG-CerC(20)) had the most dramatic effects. Transfection levels achieved for SPLP containing PEG-CerC(8) were substantially larger than observed for SPLP containing PEG-CerC(14) or PEG-CerC(20), consistent with a requirement for the PEG-ceramide to dissociate from the SPLP surface for maximum transfection potency. It is also shown that the ability of SPLP to be accumulated into cells is a dominant factor influencing transfection potency, and that the transfection potency of SPLP that are accumulated is at least equivalent to that of cationic lipid-plasmid DNA complexes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10407066     DOI: 10.1016/s0005-2736(99)00059-0

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  14 in total

Review 1.  Lipid-based nanoparticles for nucleic acid delivery.

Authors:  Weijun Li; Francis C Szoka
Journal:  Pharm Res       Date:  2007-03       Impact factor: 4.200

2.  Formation of plasmid-based transfection complexes with an acid-labile cationic lipid: characterization of in vitro and in vivo gene transfer.

Authors:  Jeremy A Boomer; David H Thompson; Sean M Sullivan
Journal:  Pharm Res       Date:  2002-09       Impact factor: 4.200

3.  Interference of poly(ethylene glycol)-lipid analogues with cationic-lipid-mediated delivery of oligonucleotides; role of lipid exchangeability and non-lamellar transitions.

Authors:  Fuxin Shi; Luc Wasungu; Anita Nomden; Marc C A Stuart; Evgeny Polushkin; Jan B F N Engberts; Dick Hoekstra
Journal:  Biochem J       Date:  2002-08-15       Impact factor: 3.857

4.  Receptor-mediated gene targeting to tissues in vivo following intravenous administration of pegylated immunoliposomes.

Authors:  N Shi; R J Boado; W M Pardridge
Journal:  Pharm Res       Date:  2001-08       Impact factor: 4.200

5.  Very long chain N4, N9 -diacyl spermines: non-viral lipopolyamine vectors for efficient plasmid DNA and siRNA delivery.

Authors:  Hassan M Ghonaim; Shi Li; Ian S Blagbrough
Journal:  Pharm Res       Date:  2008-09-10       Impact factor: 4.200

6.  Liposome-complexed adenoviral gene transfer in cancer cells expressing various levels of coxsackievirus and adenovirus receptor.

Authors:  E M Lee; S H Hong; Y J Lee; Y H Kang; K C Choi; S H Choi; I H Kim; S J Lim
Journal:  J Cancer Res Clin Oncol       Date:  2003-12-16       Impact factor: 4.553

Review 7.  Blood-brain barrier transport of non-viral gene and RNAi therapeutics.

Authors:  Ruben J Boado
Journal:  Pharm Res       Date:  2007-06-08       Impact factor: 4.200

Review 8.  Sheddable coatings for long-circulating nanoparticles.

Authors:  Birgit Romberg; Wim E Hennink; Gert Storm
Journal:  Pharm Res       Date:  2007-06-06       Impact factor: 4.200

9.  Gene silencing via RNAi and siRNA quantification in tumor tissue using MEND, a liposomal siRNA delivery system.

Authors:  Yu Sakurai; Hiroto Hatakeyama; Yusuke Sato; Mamoru Hyodo; Hidetaka Akita; Hideyoshi Harashima
Journal:  Mol Ther       Date:  2013-04-09       Impact factor: 11.454

10.  The Trojan Horse Liposome Technology for Nonviral Gene Transfer across the Blood-Brain Barrier.

Authors:  Ruben J Boado; William M Pardridge
Journal:  J Drug Deliv       Date:  2011-11-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.